Document is current
Any future updates will be listed below
-
Authors
Levy, Bruno http://orcid.org/0000-0002-7630-2908
Girerd, Nicolas
Baudry, Guillaume
Duarte, Kevin
Cuau, Samuel
Bakker, Jan
Kimmoun, Antoine
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02754193 at ClinicalTrials.govDocuments that mention this clinical trial
Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study
https://doi.org/10.1186/s13613-024-01266-6
-
Funding
Funding for this research was provided by:
PHRC
- License Information
-
More Information
Article History
Received: 12 October 2023
Accepted: 17 February 2024
First Online: 27 March 2024
Declarations
:
: The trial was approved by the French Health Authorities (Agence Nationale de la Sécurité du Médicament et des Produits de Santé: ANSM) and the appropriate Ethics Committee (Comité de Protection des Personnes: CPP Est III (N° CPP 16.04.03)).The study was registered in clinical trial registry: Trial Registration identifier NCT02754193 registered on 2016-04-12.
: Not applicable.
: Dr Baudry reported receiving personal fees from Abbott, AstraZeneca, and Boehringer, outside the submitted work. Pr Girerd reported receiving personal fees from Novartis, Bayer, AstraZeneca, Lilly, Boehringer, and Vifor, outside the submitted work. Pr Levy reported receiving personal fees from Abiomed, Gettinge, Baxter, Novartis, Sanofi, Amomed, and Orion, outside the submitted work. Pr Bakker, Pr Kimmoun, Dr Duarte and Mr Cuau reported no conflict of interest regarding this work.
